2020

1.      Gupta T,Lochan D, Verma N, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla YK, DhimanRK. Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission. J Gastroenterol Hepatol.2020;35:461-466

2.      Krishan S,Dhiman RK, Kalra N, Sharma R, Baijal SS, Arora A, Gulati A, Eapan A, Verma A, Keshava S, Mukund A, Deva S,Chaudhary R, Ganesan K, Taneja S,Gorsi U, Gamanagatti S, MadhusudanKS, Puri P, Shalimar, Govil S, Wadhavan M, Saigal S, Kumar A, Thapar S, Duseja A, Saraf N, Khandelwal A, Mukhopadyay S,Gulati A, Shetty N, Verma N.Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver andIndian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular CarcinomaIncorporating Liver Imaging Reportingand Data System" [J Clin Expt Hepatol 9 (2019) 625-651]. J Clin ExpHepatol. 2020;10:188

3.      Duseja A,De A, Taneja S, Choudhury AK,Devarbhavi H, Hu J, Hamid SS, Butt AS, JafriSMW, Ghazinian H, Chawla YK, Dhiman RK, Duan Z, Chen Y, Tan SS, Lee GH, Lim SG, Kim DJ, Sahu M, Sollano JD, CarpioG, Prasad VGM, Abbas Z, Lesmana LA, LesmanaCR, Eapen CE, Goel A, Sood A, Midha V, Goyal O, Dokmeci AK, Ning Q, Chen T, Ma K, Payawal DA, Lau GKK, MahtabMA, Rahman S, Alam MS, Shukla A, ShresthaA, Shah S, Kalal CR, Kumar G, Jain P, Paulson I, Sarin SK; APASL ACLF working Party, APASL ACLF ResearchConsortium (AARC). Impact of Metabolic Risk Factorson the Severity and Outcome of Patients with Alcohol Associated Acute- on- ChronicLiver Failure. Liver Int. 2020Sep 24. Epub ahead of print

4.      Ahmed S,Premkumar M, Dhiman RK, Kulkarni AV, Imran R, Duseja A, Kaur P, TanejaS, Singh V, Mishra S, Roy A, Mehtani R. Combined PEG3350 PlusLactulose Results in Early Resolutionof Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on- ChronicLiver Failure. J ClinGastroenterol. 2020 Oct 13. Epub ahead of print.

5.      Makkar K,Tomer S, Verma N, Rathi S, Arora SK, TanejaS, Duseja A, Chawla YK, DhimanRK. Neutrophil dysfunction predicts 90-day survival in patients with acute on chronicliver failure: A longitudinal case-control study. JGH Open. 2020;4:595-602.

6.      Roy A, Taneja S, Behera A, Kaman L, Kalra N,Chaluvashetty SB, Das A, Dahiya D, Duseja AK, Singh V. Intrahepatic Arterioportal Fistula: A Rare Cause of Portal Hypertension After Deceased Donor LiverTransplant. Exp Clin Transplant. 2020;18:645-648

7.      Taneja S, Duseja A, Mehta M, De A, Verma N,Premkumar M, Dhiman RK, Singh V, SinghMP, Ratho RK, Ramachandran R, Kumar V, Kohli HS. Sofosbuvir and Velpatasvir combination is safe and effective intreating chronic hepatitis C in end-stage renal disease on maintenance hemodialysis. Liver Int. 2020 Oct 7. Epub ahead of print.

8.      Roy A, Taneja S, Duseja AK, Singh V. Letter:long-term abdominal drains in refractory ascites-evolving conceptof palliative care in decompensated cirrhosis. Aliment PharmacolTher. 2020;52:1266-1267

9.      Pandey N,Kaushal V, Puri GD, Taneja S, BiswalM, Mahajan P, Guru RR, Malhotra P, SehgalIS, Dhooria S, Muthu V, Agarwal R. Transforming a General Hospital to an Infectious Disease Hospitalfor COVID-19 Over 2 Weeks. Front Public Health. 2020;8:382.

10.  Ragate DC, Taneja S, Roy A, Duseja AK, Dhiman RK, Singh V. Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entityin Oblivion. J Clin Exp Hepatol. 2020.(In press correctedproof)

11. Taneja S, Mehtani R, Chawla YK. Gastrointestinal and Liver Manifestations of COVID-

19. Ann Natl Acad Med Sci (India) 2020;00:1–7.

12.  Agarwal A, Taneja S, Chopra M, Duseja A, DhimanRK. Animal Naming Test – a simple and accurate test for diagnosis ofminimal hepatic encephalopathy and predictionof overt hepaticencephalopathy. Clin ExpHepatol 2020; 6, 2: 116–124.

13.  Taneja S, Roy A. Nonalcoholicsteatohepatitis recurrence after liver transplant. Transl Gastroenterol Hepatol. 2020 Apr 5;5:24.

14.  Kumar A, Acharya SK, SinghSP, Arora A, Dhiman RK, Aggarwal R, Anand AC, BhanguiP, Chawla YK, Datta Gupta S, Dixit VK, Duseja A, Kalra N, Kar P,Kulkarni SS, Kumar R, Kumar M,Madhavan R, Mohan Prasad VG, Mukund A, Nagral A, Panda D, Paul SB, Rao PN, Rela M, Sahu MK, Saraswat VA, Shah SR,Shalimar, Sharma P, Taneja S, Wadhawan M; INASL Task-Forceon Hepatocellular Carcinoma. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinomain India: The Puri II Recommendations. J ClinExp Hepatol. 2020Jan-Feb;10(1):43-80.

15.  Shrestha D,Rathi S, Grover S, Taneja S, DusejaA, Chawla YK, Dhiman RK. Factors AffectingPsychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient. J Clin Exp Hepatol. 2020 Jan-Feb;10(1):9-16.

16.  Dhiman RK,Thumburu KK, Verma N, Chopra M, Rathi S, Dutta U, Singal AK, Taneja S,Duseja A, Singh M. Comparative Efficacy of Treatment Options for MinimalHepatic Encephalopathy: A SystematicReview and Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020Apr;18(4):800-812.e25.

2019

17.  Thakur J,Rathi S, Grover S, Chopra M, Agrawal S, TanejaS, Duseja A, Bhansali A, ChawlaYK, Dhiman RK. Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With LiverCirrhosis. J Clin Exp Hepatol.2019;9:312-317.

18.  Sarin SK,Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ,Dhiman RK, Duseja A, Taneja S.Acute-on- chronic liver failure:consensus recommendations of the Asian Pacific association for the study ofthe liver (APASL): an update. HepatolInt. 2019;13:353-390

19.  Sahu SK,Chawla YK, Dhiman RK, Singh V, Duseja A, TanejaS, Kalra N, Gorsi U. Rupture ofHepatocellular Carcinoma: A Review of Literature. J Clin Exp Hepatol. 2019 Mar-Apr;9(2):245-256.

20.  DevarbhaviH, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C,Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, TreeprasertsukS, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, AbbasZ, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, KedarisettyCK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients. Am J Gastroenterol. 2019 Apr 22.

21.  Dhiman RK,Grover GS, Premkumar M, Taneja S,Duseja A, Rathi S, Satsangi S. Direct- acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The PublicHealth Perspective. J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):74-80

22.  Anand L,Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Siam Tan S, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab

MA, GhazinyanH, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, LesmanaLA, Lesmana CR, Sollano JD, Carpio G,Sahu MK, Kumar G, Sarin SK; APASL ACLF (APASL ACLF Research Consortium) Working Party. Flare of Autoimmune Hepatitis Causing Acute onChronic Liver Failure: Diagnosis and Responseto Corticosteroid Therapy.Hepatology. 2019 Aug;70(2):587-596.

23.  Sahu SK, Taneja S, Kalra N, Dhiman RK, ChawlaYK, Duseja A, Singh V. Rupture of Hepatocellular Carcinoma: a Tale of 20Cases from a Tertiary Care Center in NorthernIndia. J Gastrointest Cancer. 2019 Sep;50(3):596-600.

24.  Dhiman RK,Grover GS, Premkumar M, Taneja S,Duseja A, Arora S, Rathi S, Satsangi S, Roy A; MMPHCRFInvestigators. Decentralized care with genericdirect-acting antivirals inthe management of chronic hepatitis C in a public health care setting. J Hepatol.2019 Dec;71(6):1076-1085.

2018

25.  Roy A, Taneja S. Type of organ failure andacute insult have important bearings in outcomesof liver transplantation: A pragmatic discourse. J Hepatol. 2018 Nov 3. pii: S0168-8278(18)32384-5.

26.  Verma N,Singh S, Taneja S, Duseja A, SinghV, Dhiman RK, Chakrabarti A, Chawla YK.Invasive fungal infections amongstpatients with acute-on-chronic liverfailure at high risk forfungal infections. Liver Int. 2018 Oct 1. [Epub ahead of print]

27.  Taneja S, Duseja A, De A, Kumar V,Ramachandran R, Sharma A, Dhiman RK, Gupta KL,Chawla Y. Successful treatment of chronic hepatitis C infection with directlyacting antivirals in renal transplant recipients. Nephrology (Carlton). 2018;23:876-882.

28.  Satsangi S,Duseja A, Sachdeva M, Tomer S, Arora SK, TanejaS, Dhiman RK, Chawla YK. Monocytehuman leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients ofdecompensated cirrhosis with and without acute-on chronic liverfailure. PLoS One. 2018;13:e0200644.

29.  Taneja S, Kumar P, Mitra S, Duseja A, MinzR, Das A, Dhiman RK, Chawla Y. Acute Exacerbationto Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature. J Clin Exp Hepatol.2018;8:98-103.

30.  Taneja S, Duseja A, De A, Mehta M,Ramachandran R, Kumar V, Kohli HS, Gupta KL,Dhiman RK, Chawla Y. Low-DoseSofosbuvir Is Safe and Effectivein Treating Chronic

Hepatitis C inPatients with Severe Renal Impairment or End-Stage Renal Disease. Dig Dis Sci. 2018;63:1334-1340.

31.  RamachandranR, Yadav AK, Kumar V, Varma A, Taneja S,Nada R, Gupta KL, Jha V. PLA2R relatedprimary membranous nephropathy in a hepatitisC positive patient.Nephrology (Carlton).2018;23:288.

2017

32.  Verma N,Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A,Dhiman RK, Chawla Y. Drugidiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature. Hepatol Commun. 2017;2:142-147.

33.  Rathi S, Taneja S. Terminating and episode of overt hepaticencephalopathy: L- ornithine-L-aspartate may have some role.Hepatology. 2017 Oct 10. [Epub ahead of print]

34. Taneja S, Borkakoty A, Rathi S, Kumar V, Duseja A, Dhiman RK, Gupta KL, Chawla

Y. Assessment of Liver Fibrosisby Transient Elastography Should Be Done After Hemodialysis in End Stage Renal DiseasePatients with Liver Disease. Dig Dis Sci. 2017;62:3186-3192.

35.  Kumar P, Taneja S, Singh V. Beta-blockers inpatients with advanced liver disease: Has the dust settled? Liver Transpl.2017;23:1351-1352.

36.  Kumar P, Taneja S, Singh V. Does the dose andtype of nonselective beta-blocker really matter? Hepatology. 2017;66:301-302.

37.  Gupta T,Dhiman RK, Ahuja CK, Agrawal S, Chopra M, Kalra N, Duseja A, Taneja S, Khandelwal N, Chawla Y. Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure. JClin Exp Hepatol. 2017;7:190-197.

38.  ChoudhuryA, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, Mahtab M, Rahman S, Chawla YK, Taneja S, Tan SS, Devarbhavi H, Duan Z, Yu C, Ning Q, Jia JD, Amarapurkar D, Eapen CE, Goel A, HamidSS, Butt AS, Jafri W, Kim DJ, Ghazinian H, LeeGH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Dokmeci AK, Sollano JD, Carpio G, Lau GK, Karim F, Rao PN,Moreau R, Jain P, Bhatia P, Kumar G, Sarin SK;APASL ACLF Working Party. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF):comparison of APASL ACLF research consortium(AARC) and CLIF-SOFA models. Hepatol Int. 2017 Aug 30. [Epub aheadof print]

39.  Taneja S, Kumar P, Rathi S, Duseja A, SinghV, Dhiman RK, Chawla YK. Acute Liver FailureDue to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based CausalityAssessment. Ann Hepatol.2017;16:818-821.

40.  Verma N,Sharma M, Biswal M, Taneja S, BatraN, Kumar A, Dhiman RK. Hepatitis E Virus Induced Acute Liver Failure withScrub Typhus Coinfection in a Pregnant Woman.J Clin Exp Hepatol. 2017;7:158-160

41.  Mehta M,Satsangi S, Duseja A, Taneja S,Dhiman RK, Chawla Y. Can Alcoholic Liver Diseaseand Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol. 2017;7:121- 126.

42.  Taneja S, Kumar P, Gautam V, Duseja A,Singh V, Dhiman RK, Chawla Y. Spontaneous Bacterial Peritonitis by Burkholderia cepaciaComplex: A Rare, Difficult to Treat Infectionin Decompensated Cirrhotic Patients. J Clin Exp Hepatol. 2017;7:102-106.

43.  Taneja S, Chawla YK. Perioperative use ofterlipressin in adult liver transplant. LiverTranspl. 2017;23:995-996.

44.  Kumar P, Taneja S, Gupta K, Duseja A, Dhiman RK,Chawla YK. Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult. J Clin Exp Hepatol.2017;7:77-79.

45.  Gupta T,Dhiman RK, Rathi S, Agrawal S, Duseja A, TanejaS, Chawla Y. Impact of Hepaticand Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure. J Clin ExpHepatol. 2017;7:9-15.

46.  Satsangi S,Mehta M, Duseja A, Taneja S, DhimanRK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effectiveas triple therapy with Pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patientswith chronic hepatitis C. J Gastroenterol Hepatol. 2017;32:859-863.

47.  Borkakoty A, Kumar P, Taneja S. HepaticEncephalopathy. N Engl J Med. 2017;12;376:186.

2016

48.  Taneja S, TohraS, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver FibrosisBy Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-AnExperience from a Tertiary Care Hospital. JClin Exp Hepatol. 2016;6:282-290.

49.  Kumar P, Taneja S, Singh V. Treatmentof Patients with Cirrhosis. N Engl J Med. 2016;375:2102-3.

50.  Taneja S, Kumar P, DusejaA, Singh V, Dhiman RK, Chawla Y. Honeycomb Cyst of the Liver.J Clin Exp Hepatol. 2016;6:250-251.

51.  Taneja S, BorakoktyA, Duseja A, Dhiman RK, Chawla Y. Acute Liver Failure Causedby Hepatitis A Virus with DengueCoinfection. J Clin Exp Hepatol. 2016;6:164.

2015

52.  Taneja S, Sakpal M, Ranjan R, Duseja A,Dhiman PK, Chawla YK. Hepatology: Hepato splenicsarcoidosis presenting as cholestatic jaundice and severe constitutionalsymptoms mimicking malignancy. J Gastroenterol Hepatol. 2015;30:968.

53.  PrabhakarN, Vyas S, Taneja S, Khandelwal N.Intrahepatic aneurysmal portohepatic venousshunt: what should be done? Ann Hepatol. 2015;14:118-20.

2014

54.  Gupta S, Taneja S. Livertransplantation for portal cavernoma cholangiopathy. J Clin Exp Hepatol.2014;4(Suppl 1):S85-7.

55.  Dhiman RK,Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS,Bhatia V, Sharma M, Kumar M, Gupta S, TanejaS, Kaman L, Zargar SA, Nundy S,Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of theIndian national association for study of the liver. J Clin Exp Hepatol. 2014;4(Suppl 1):S2-S14.

56.  Taneja S, Wadhawan M, Gupta S, Goyal N,Ramaswamy KV, Chaudhary A. Congenital hepaticfibrosis with extra-hepatic porto-systemic shunt and hepatopulmonary syndrome successfully managed with living related liver transplantation. Trop Gastroenterol. 2014;35:116-8.

2013

57.  Taneja S, Gupta S, Wadhawan M, Goyal N.Single-lobe living donor liver transplant in amorbidly obese cirrhotic patient preceded by laparoscopic sleevegastrectomy. Case Rep Transplant. 2013;2013:279651.

58.  Wadhawan M, Gupta S, Goyal N, Taneja S, Kumar A. Living related livertransplantation for hepatitis B-related liver disease without hepatitisB immune globulin prophylaxis. Liver Transpl. 2013;19:1030-5.

59.  Wadhawan M, Kumar A, Gupta S, Goyal N, Shandil R, Taneja S, Sibal A. Post-transplant biliary complications: an analysisfrom a predominantly living donor liver transplant center. J Gastroenterol Hepatol. 2013;28:1056-60.

60.  Taneja S, Chawla Y, Dhiman RK. Noncirrhoticportal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation. Hepatol Int.2013;7:313-5.

61.  Gupta S, Taneja S, Duseja A, Dhiman RK, ChawlaY, Kalra N, ArunanshuBehera. Giant hydatid cyst of the liver. TropicalGastroenterology 2013;34:112–113

2012

62.  Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla

Y. Inhibitory controltest for the detection of minimal hepatic encephalopathy in patients withcirrhosis of liver. J Clin ExpHepatol. 2012;2:306-14.

63.  Thumburu KK, Taneja S, VasishtaRK, Dhiman RK. Neuropathology of acute liverfailure. Neurochem Int. 2012;60:672-5.

2011

64.  Taneja SK, Dhiman RK. Preventionand management of bacterial infections in cirrhosis. Int J Hepatol. 2011;2011:784540.

65.  Tohra SK, Taneja S, Ghosh S, Sharma BK, Duseja A,Dhiman RK, Das A, Chawla YK. Prediction of sustained virological response to combination therapy with pegylatedinterferon alfa and ribavirin in patients with genotype 3 chronichepatitis C. Dig Dis Sci. 2011;56:2449-55.

66.  Taneja S, Kalra N, Dhiman RK, Chawla YK. An abnormal portal vein. Liver Int. 2011;31:65.

67.  Taneja S, Sharma A, Duseja A, Kalra N, Dhiman RK, Chawla Y. Spontaneous perforation of gallbladder with intrahepatic bilioma. Journal ofClinical and Experimental Hepatology 2011.1(3) Dec 210-211

68.  Taneja S, Chawla Y, Dhiman RK. Noncirrhoticportal fibrosis: a rare cause of end-stage liver diseaserequiring liver transplantation. Hepatol Int. 2011 Sep 3. Epub ahead of print

69.  Wadhawan M,Kumar A, Taneja S. Biliarycomplications after liver transplant. Indianjournal of organ transplantation.2011;5:96-101

70.  Taneja S, Dhiman RK. Non Cirrhotic PortalFibrosis and Gamma Gandy bodies. Journal of Clinicaland Experimental Hepatology 2011;1:48

2010

71.  Duseja A,Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insultsare common acute precipitants inpatients with acute on chronic liverfailure (ACLF). Dig DisSci. 2010;55:3188-92.

72.  Taneja S, Kalra N, Duseja A, Dhiman RK.Noncirrhotic portal fibrosis and abdominal varices. Liver Int. 2010;30:715-7.

73.  Puri R,Vilmann P, Sud R, Kumar M, Taneja S,Verma K, Kaushik N. Endoscopic ultrasound-guided fine-needle aspiration cytology in the evaluation of suspected tuberculosis in patients with isolated mediastinal lymphadenopathy. Endoscopy. 2010;42:462-7.

74.  Taneja S, Khanna S, Puri R, Saraf N, Sud R.Dual endoscopic therapy for Dieulofoy’s like lesion in duodenaldiverticulum: A case report. Journalof Digestive Endoscopy.2010;1:69-72.

2007

75.  Taneja S, Das K, Saigal S, Ranjan P, JainS, Garg N, Malik VK, Arora A. Oesophageal leiomyoma: Case report and reviewof literature. Trop Gastroenterol. 2007;28:131-2.

2004

76.  Mahajan SK,Taneja S, Sharma D, Sharma S.Pulmonary artery aneurysm. The Indian Practitioner 2004; 57:314.

2003

77.  SK Mahajan,PC Machan, BR Sood, S Taneja, R Raina, S Thakur, LS Pal.Pitting oedema in Hypothyroidism. JAPI 2003; 51:885.